Cancer Management and Research

Trends in Emerging Cancer Vaccines and Immunotherapies

Cancer vaccines have been in research at both pre-clinical and clinical levels for decades and the field continues to expand to address the unmet need of cancer therapy with minimal adverse events. Cancer vaccines are of two kinds, preventative and therapeutic. Two FDA approved preventative cancer vaccines include vaccines against human papillomavirus and hepatitis B virus responsible for cervical cancer and hepatitis B respectively. Additionally, three FDA approved therapeutic vaccines are available against prostate cancer, bladder cancer, and melanoma. These limited number of FDA approved cancer vaccines contrast the impact diverse forms of cancers have on the global population.